S 712 Pill: brown, round, 12mm
The pill with imprint S 712 (Brown, Round, 12mm) has been identified as Topiramate 200 mg and is used for Lennox-Gastaut Syndrome, Migraine Prevention, Epilepsy, Seizure Prevention, and Seizures. It belongs to the drug class carbonic anhydrase inhibitor anticonvulsants and is not a controlled substance.
Images for S 712
Topiramate
- Imprint
- S 712
- Strength
- 200 mg
- Color
- Brown
- Size
- 12.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharmaceuticals
- Inactive Ingredients
-
lactose anhydrous,
microcrystalline cellulose,
corn starch,
sodium starch glycolate type A potato,
magnesium stearate,
polyvinyl alcohol,
titanium dioxide,
polyethylene glycol,
magnesium silicate,
ferric oxide red,
soya lecithin,
ferrosoferric oxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 47335-0712 | Sun Pharmaceutical Industries Inc. |
| 62756-0712 | Sun Pharmaceutical Industries Inc. |
Related images for "S 712"
Featured
Semaglutide
Semaglutide is a GLP-1 agonist used for weight loss, type 2 diabetes, and reducing cardiovascular ...
Reviews & ratings
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,343)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR, Topiragen
Professional resources
- Topiramate monograph
- Topiramate (FDA)
- Topiramate Capsules (FDA)
- Topiramate ER Capsules (FDA)
- Topiramate Oral Solution (FDA)
- Topiramate Tablets (FDA)
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.